Healthcare -
Medical - Diagnostics & Research - NYSE - US
$ 164.695
-0.372 %
$ 8.42 B
Market Cap
823.47
P/E
CASH FLOW STATEMENT
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
Charles River Laboratories International, Inc.
| Net Income | 25.3 M |
| Depreciation & Amortization | 362 M |
| Capital Expenditures | -233 M |
| Stock-Based Compensation | 69.9 M |
| Change in Working Capital | -30.3 M |
| Others | 321 M |
| Free Cash Flow | 502 M |
Cash Flow
Millions
| Dec-2024 | Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | Dec-2016 | Dec-2015 | Dec-2014 | Dec-2013 | Dec-2012 | Dec-2011 | Dec-2010 | Dec-2009 | Dec-2008 | Dec-2007 | Dec-2006 | Dec-2005 | Dec-2004 | Dec-2003 | Dec-2002 | Dec-2001 | Dec-2000 | Dec-1999 | Dec-1998 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| OPERATING CASH FLOW | |||||||||||||||||||||||||||
| Net Income | 25.3 | 480.4 | 492.6 | 398.8 | 365.3 | 254.1 | 227.2 | 125.6 | 156.1 | 152.0 | 129.9 | 105.4 | 102.1 | 115.5 | (334.1) | 109.4 | (522.3) | 154.4 | (55.8) | 142.0 | 89.8 | 80.2 | 50.1 | 35.4 | 17.9 | 17.1 | 23.4 |
| Depreciation & Amortization | 361.7 | 314.1 | 303.9 | 265.5 | 234.9 | 198.1 | 161.8 | 131.2 | 126.7 | 94.9 | 96.4 | 96.6 | 81.3 | 85.2 | 93.6 | 93.6 | 91.2 | 88.9 | 85.1 | 104.6 | 48.2 | 31.1 | 25.7 | 28.6 | 18.9 | 15.6 | 10.9 |
| Deferred Income Tax | (67.4) | (50.9) | (35.9) | (24.0) | (0.1) | (21.9) | (9.7) | 28.3 | 1.9 | 2.7 | 7.1 | (0.8) | 1.3 | (8.7) | (42.3) | 15.8 | 12.7 | (9.8) | 4.0 | (37.4) | 9.1 | 8.9 | 11.3 | 17.2 | (0.9) | 8.6 | (3.1) |
| Stock Based Compensation | 69.9 | 72.0 | 73.6 | 71.5 | 56.3 | 57.3 | 47.3 | 44.0 | 43.6 | 40.1 | 31.0 | 24.5 | 21.9 | 21.7 | 25.5 | 23.8 | 24.3 | 0 | 21.1 | 17.0 | 3.8 | 0 | 1.0 | 4.5 | 0 | 0 | 0 |
| Other Operating Activities | 375.4 | (29.4) | (62.0) | 6.0 | (83.6) | (12.8) | (0.3) | (18.7) | 6 K | (13.0) | (9.6) | 6.7 | 27.4 | 18.5 | 418.7 | 25.9 | 706.2 | 10.4 | 168.5 | 21.0 | 21.8 | 8.5 | 28.9 | 6.6 | (1.0) | (0.9) | (1.2) |
| Change in Working Capital | (30.3) | (102.4) | (152.6) | 42.9 | (26.3) | 6.2 | 14.8 | 5.9 | (30.0) | 9.6 | (3.8) | (25.4) | (26.0) | (27.0) | 7.6 | (43.4) | (32.2) | 19.2 | (58.6) | (10.5) | 12.2 | (4.9) | 16.7 | (20.9) | (9.3) | (2.9) | 7.4 |
| Cash From Operations | 734.6 | 683.9 | 619.6 | 760.8 | 546.6 | 480.9 | 441.1 | 316.3 | 298.3 | 286.4 | 251.1 | 207.1 | 207.9 | 205.3 | 169.0 | 225.0 | 279.9 | 284.2 | 164.4 | 236.7 | 184.8 | 123.8 | 133.7 | 71.3 | 33.8 | 37.6 | 37.4 |
| INVESTING CASH FLOW | |||||||||||||||||||||||||||
| Capital Expenditures | (233.0) | (318.5) | (324.7) | (228.8) | (166.6) | (140.5) | (140.1) | (82.4) | (55.3) | (63.3) | (56.9) | (39.2) | (47.5) | (49.1) | (42.9) | (80.0) | (197.1) | (227.0) | (181.7) | (95.5) | (45.3) | (32.7) | (37.5) | (36.7) | (15.6) | (13.0) | (11.9) |
| Other Items | (12.1) | (244.6) | (283.2) | (1 209.2) | (435.0) | (541.0) | (814.9) | 9.8 | (631.1) | (257.0) | (241.1) | (34.9) | (7.5) | 12.5 | 48.6 | (128.8) | (30.1) | 26.3 | 73.8 | (18.4) | (554.6) | (30.7) | (41.3) | (55.3) | 1.0 | (21.2) | (11.1) |
| Cash From Investing Activities | (245.1) | (563.2) | (607.9) | (1 437.9) | (601.5) | (681.5) | (955.0) | (72.6) | (686.4) | (320.3) | (298.0) | (74.0) | (55.0) | (36.6) | 5.8 | (208.8) | (227.2) | (200.8) | (108.0) | (114.0) | (600.0) | (63.4) | (78.9) | (91.9) | (14.6) | (34.2) | (23.0) |
| FINANCING CASH FLOW | |||||||||||||||||||||||||||
| Common Stock Repurchased | (119.2) | (24.2) | (38.7) | (40.7) | (24.0) | (18.1) | (13.8) | (106.9) | (12.3) | (117.5) | (122.0) | (165.9) | (64.2) | (283.8) | (356.5) | (45.9) | (115.1) | (41.6) | (250.0) | (18.0) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Debt Repaid | (412.2) | (75.3) | 19.8 | 670.0 | 30.6 | 233.9 | 554.0 | (135.6) | 388.0 | 75.2 | 104.4 | (11.5) | (66.2) | (2.3) | 197.8 | (36.1) | 65.5 | (64.5) | 269.5 | (203.6) | 412.5 | (10.1) | 1.0 | (71.6) | (203.0) | 337.5 | (1.1) |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | (1.9) | (1.4) | (2.1) | (1.9) | (1.5) | (0.7) | 0 | 0 | 0 |
| Other Financing Activities | (19.6) | 14.0 | (23.5) | 43.3 | 40.6 | 16.2 | 17.9 | 34.0 | 15.0 | 46.8 | 79.0 | 93.2 | 19.3 | 14.3 | (9.2) | 1.1 | 32.3 | 59.7 | (102.3) | 0.5 | 0 | (0.8) | 0.3 | 2.8 | (32.2) | (452.0) | (6.9) |
| Cash From Financing Activities | (550.9) | (85.5) | (42.4) | 672.6 | 47.2 | 231.9 | 558.1 | (208.5) | 390.7 | 4.5 | 61.4 | (84.2) | (111.1) | (271.8) | (167.9) | (81.0) | (17.3) | (46.4) | 5.4 | (197.6) | 436.9 | (8.8) | 5.2 | 47.2 | 0.8 | (11.5) | (8.0) |
| CHANGE IN CASH | |||||||||||||||||||||||||||
| Net Change In Cash | (78.9) | 43.3 | (5.1) | 13.2 | (6.9) | 42.7 | 31.0 | 46.4 | (0.3) | (42.1) | 4.1 | 46.2 | 40.8 | (110.3) | (3.4) | (61.0) | 18.1 | 50.1 | 60.6 | (92.7) | 25.2 | 59.8 | 64.2 | 25.1 | 18.1 | (9.8) | 6.9 |
| FREE CASH FLOW | |||||||||||||||||||||||||||
| Free Cash Flow | 501.6 | 365.4 | 294.9 | 532.0 | 380.0 | 340.4 | 301.1 | 233.8 | 243.0 | 223.1 | 194.1 | 168.0 | 160.4 | 156.1 | 126.2 | 145.0 | 82.9 | 57.2 | (17.4) | 141.2 | 139.5 | 91.1 | 96.1 | 34.6 | 18.2 | 24.6 | 25.5 |